# Evidence Amyloid Scan EEG Study

> **NCT03644043** · — · UNKNOWN · sponsor: **Metabolic Therapy Inc.** · enrollment: 2000 (estimated)

## Conditions studied

- Alzheimer Disease
- Dementia Frontal
- Mild Cognitive Impairment

## Interventions

- **DEVICE:** EEG scan

## Key facts

- **NCT ID:** NCT03644043
- **Lead sponsor:** Metabolic Therapy Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-20
- **Primary completion:** 2020-11-15
- **Final completion:** 2020-11-30
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2018-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03644043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03644043, "Evidence Amyloid Scan EEG Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03644043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*